← Leaderboards
Rob Caudle
Duke University
$7,252,732
Attributed
$7,252,732
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.1M · FY2016–22$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$7,252,732 · 2
By mechanism
N01$7,252,732 · 2
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- John A Bartlett$46,300,629
- Emmanuel B Walter$22,544,318
- Michael Barry Kastan$65,974,699
- Thomas Denny$80,103,265
- Joe Brice Weinberg$9,293,887
Others in their field
Top investigators on “Investigation”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$681,473,477
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$448,008,305
- Judith S. Currier · University Of California Los Angeles$395,422,692
Research focus
InvestigationNovel TherapeuticsInfectious Disease TreatmentPhase I Clinical TrialsClinical Trials UnitTherapeutic AgentsNational Institute Of Allergy And Infectious DiseaseImmunomodulatorsViralResource DevelopmentPathogenParasitic DiseasesBiodefensePhase I TrialProtocol DevelopmentCommunicable DiseasesChikungunya VirusTherapeutic EvaluationContractsOperationImmunoregulationMalariaEnsureCovid-19
Grant awards (11)
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: CHIKUNGUNYA VIRUS$1,386,229
N01 · FY2022 · AI · contact PI
Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases$136,871
N01 · FY2022 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS AGAINST INFECTIOUS DISEASES: ADMINISTRATIVE SUPPORT$109,972
N01 · FY2021 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: CHIKUNGUNYA VIRUS$46,368
N01 · FY2021 · AI · contact PI
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT (COVID-19)$996,432
N01 · FY2020 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: CHIKUNGUNYA VIRUS$228,850
N01 · FY2020 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: CHIKUNGUNYA VIRUS$700,013
N01 · FY2019 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF MALARIA THERAPEUTICS$2,088,140
N01 · FY2018 · AI · contact PI
Phase 1 Clinical Trial Units for Therapeutics Against Infectious Diseases: Evaluation of Therapeutics for Resistant Bacterial Infections$1,281,164
N01 · FY2017 · AI · contact PI
PHASE 1 CLINICAL TRIAL UNITS FOR THERAPEUTICS: EVALUATION OF MALARIA THERAPEUTICS$40,257
N01 · FY2017 · AI · contact PI
Phase I Unit for Therapeutics Research$238,436
N01 · FY2016 · AI · contact PI